Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 21, 2024Biomedicine & PharmacotherapyOpen Access

Cardioprotective potentials of myricetin on doxorubicin-induced cardiotoxicity based on biochemical and transcriptomic analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

JLJaili LiTLTing LuoYZYao Zhao

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (2024) studied this question.

synapsesocial.com/papers/68e69105b6db643587617cfbhttps://doi.org/10.1016/j.biopha.2024.116748
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1In-silico and In-vivo Investigations Reveal Ameliorative Potential of Myricetin Against Doxorubicin-induced Myocardial Damage via Modulation of NF-κB Signaling Pathway2025
  2. 2Myricitrin Protects against Doxorubicin‐Induced Cardiotoxicity by Counteracting Oxidative Stress and Inhibiting Mitochondrial Apoptosis via ERK/P53 Pathway2016 · 53 citations
  3. 3Myricetin Prevents Doxorubicin-Induced Oxidative Stress, Apoptotic Pathway, and Inflammation in H9C2 Cardiac Cells2026
  4. 4Myricetin Prevents Doxorubicin-Induced Oxidative Stress and Mitochondrial Apoptotic Pathway in H9C2 Cardiac Cells2025
  5. 5Myricetin protects against doxorubicin-induced liver damage by modulating oxidative and inflammatory pathways2026